QSC Tirzepatide API Powder - Competitive Price for Clinical Study Applications

QSC Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist under investigation for metabolic disorders. This synthetic peptide demonstrates superior glycemic control and weight management properties compared to single-agonist therapies.

As a research chemical, QSC Tirzepatide offers scientists a powerful tool to study:
- Dual receptor activation mechanisms
- Comparative efficacy versus single agonists
- Long-term metabolic effects
- Potential applications in obesity and diabetes management

Our pharmaceutical-grade QSC Tirzepatide is produced under strict GMP conditions with comprehensive quality control including HPLC, MS, and AAA analysis. The lyophilized powder maintains excellent stability when stored properly.

Key advantages of our QSC Tirzepatide:
- 99.7% purity verified by multiple analytical methods
- Batch-to-batch consistency
- Customizable concentrations (5mg-30mg)
- Third-party testing reports available

This product is intended for research use only by qualified professionals in laboratory settings. Not for human consumption or diagnostic use.